Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 4Zollinger-Ellison Syndrome 1Unspecified Childhood Solid Tumor, Protocol Specific 1Somatostatinoma 1Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Pinealoma 1Paraganglioma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Insulinoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Glucagonoma 1Glioma 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Chondrosarcoma, Extraskeletal Myxoid 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoma, Hepatocellular 1Brain Stem Neoplasms 1Adult Solid Neoplasm 1

Interventions

Filgrastim 7Peripheral Blood Stem Cell Transplantation 4Melphalan 4Etoposide 4Carboplatin 4Busulfan 4Ifosfamide 3Granulocyte Colony-Stimulating Factor 3tanespimycin 2Thiotepa 2Temozolomide 2Mesna 2Docetaxel 2Cyclophosphamide 2trioctyl phosphine oxide 1temsirolimus 1sargramostim 1pegfilgrastim 1omburtamab I-131 1montanide ISA 51 1ixabepilone 1ganitumab 1entinostat 1cixutumumab 1amino-acid, glucose, and electrolyte solution 1alvocidib 1aldesleukin 1Valproic Acid 1Transplantation 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neuroectodermal Tumors, Primitive, Peripheral × cixutumumab × Clear all
NCT00609141 2014-06-19

IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor

National Cancer Institute (NCI)

Phase 1 Completed
34 enrolled

Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡